A significant reduction in the incidence of NEC following
antenatal glucocorticoid therapy has been reported in
several large, randomized control trials. Although
antenatal glucocorticoid therapy might be a simple and
effective strategy for global prevention of NEC, more
research should focus on the potential impact on neurodevelopment
outcome.